BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 24406296)

  • 21. Rho kinase mediates Porphyromonas gingivalis outer membrane vesicle-induced suppression of endothelial nitric oxide synthase through ERK1/2 and p38 MAPK.
    Jia Y; Guo B; Yang W; Zhao Q; Jia W; Wu Y
    Arch Oral Biol; 2015 Mar; 60(3):488-95. PubMed ID: 25555250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
    Zhou H; Zhang KX; Li YJ; Guo BY; Wang M; Wang M
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):387-94. PubMed ID: 21457293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
    Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
    J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
    Li WJ; Park K; Paick JS; Kim SW
    J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasudil inhibits platelet-derived growth factor-induced human pulmonary artery smooth muscle cell proliferation by up-regulation of p27kip¹ via the ERK signal pathway.
    Liu AJ; Ling F; Wang D; Wang Q; Lü XD; Liu YL
    Chin Med J (Engl); 2011 Oct; 124(19):3098-104. PubMed ID: 22040563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
    Yamaguchi S; Tanabe K; Takai S; Matsushima-Nishiwaki R; Adachi S; Iida H; Kozawa O; Dohi S
    Neurochem Int; 2009 Nov; 55(6):438-45. PubMed ID: 19427347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RhoA/ROCK pathway mediates high glucose-induced cardiomyocyte apoptosis via oxidative stress, JNK, and p38MAPK pathways.
    Zhou H; Sun Y; Zhang L; Kang W; Li N; Li Y
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3022. PubMed ID: 29745021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
    Hofni A; Shehata Messiha BA; Mangoura SA
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor.
    Hata Y; Miura M; Nakao S; Kawahara S; Kita T; Ishibashi T
    Jpn J Ophthalmol; 2008; 52(1):16-23. PubMed ID: 18369695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
    Takeba Y; Matsumoto N; Watanabe M; Takenoshita-Nakaya S; Ohta Y; Kumai T; Takagi M; Koizumi S; Asakura T; Otsubo T
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1545-55. PubMed ID: 22481618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Rho kinase inhibitor fasudil attenuates Aβ
    Gao Y; Yan Y; Fang Q; Zhang N; Kumar G; Zhang J; Song LJ; Yu J; Zhao L; Zhang HT; Ma CG
    Metab Brain Dis; 2019 Dec; 34(6):1787-1801. PubMed ID: 31482248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
    Xueyang D; Zhanqiang M; Chunhua M; Kun H
    Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Rho kinase inhibitor fasudil augments the number of functional endothelial progenitor cells in ex vivo cultures.
    O E; Ahn HY; Kim HK; You JC; Shin JC; Joe YA
    Int J Mol Med; 2011 Sep; 28(3):357-63. PubMed ID: 21567077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
    Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
    J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways.
    Li Y; Cao Y; Zeng Z; Liang M; Xue Y; Xi C; Zhou M; Jiang W
    Sci Rep; 2015 Feb; 5():8209. PubMed ID: 25644821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide impairs permeability of pulmonary microvascular endothelial cells via Connexin40.
    Zhou HS; Li M; Sui BD; Wei L; Hou R; Chen WS; Li Q; Bi SH; Zhang JZ; Yi DH
    Microvasc Res; 2018 Jan; 115():58-67. PubMed ID: 28870649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat stress prevents lipopolysaccharide-induced apoptosis in pulmonary microvascular endothelial cells by blocking calpain/p38 MAPK signalling.
    Liu ZF; Zheng D; Fan GC; Peng T; Su L
    Apoptosis; 2016 Aug; 21(8):896-904. PubMed ID: 27325431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.